medication schedule: once every 4 weeks, 6 times after continuous administration , Effectiveness observation to week 48
Sponsors
Beijing Union Medical College Hospital, Chinese Academy of Medical Sciences
Conditions
Diabetic macular edemaWet age-related macular degeneration
Phase 2
Phase Ib / IIa clinical study on the safety and efficacy of BAT5906 injection in patients with diabetic macular edema
Active, not recruitingChiCTR2000032727
Start: 2020-07-01Updated: 2020-05-11
Phase II Clinical Study on the Efficacy and Safety of BAT5906 Injection in Patients With Wet Age-Related Macular Degeneration
Active, not recruitingChiCTR2000032723
Start: 2020-07-01Updated: 2020-05-11